PCM
TELA icon

Prelude Capital Management’s TELA Bio TELA Stock Holding History

Prelude Capital Management’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,087
Closed -$36.5K – 1521
2024
Q4 		$36.5K Buy
+12,087
New +$34K ﹤0.01% 1159

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Prelude Capital Management's TELA Position: Q1 2025 in Review

Prelude Capital Management sold out of TELA Bio (TELA) in Q1 2025, closing a stake of 12,087 shares — an estimated $36.5K sold.

Prelude Capital Management first reported a position in TELA in Q4 2024 and held it in 1 quarter. The position peaked at $36.5K in Q4 2024. 50 funds tracked by Wall St. Rank hold TELA as of Q1 2025.

  • Prelude Capital Management reported no remaining TELA Bio position as of Q1 2025 after selling out during the quarter.
  • Prelude Capital Management sold 12,087 TELA Bio shares in Q1 2025, an estimated $36.5K.
  • Prelude Capital Management first reported a position in TELA Bio in Q4 2024 and held it in 1 quarter.
  • Prelude Capital Management's TELA Bio position peaked at $36.5K in Q4 2024.
  • 50 funds tracked by Wall St. Rank held TELA Bio as of Q1 2025.

Based on Prelude Capital Management's 13F filing for Q1 2025, filed 15 May 2025.